HR
CMD

Howe & Rusling’s Cantel Medical Corporation CMD Stock Holding History

Howe & Rusling’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-300
Closed -$16K – 1092
2015
Q2 		$16K Buy
+300
New +$14.6K ﹤0.01% 449

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Howe & Rusling's CMD Position: Q3 2015 in Review

Howe & Rusling sold out of Cantel Medical Corporation (CMD) in Q3 2015, closing a stake of 300 shares — an estimated $16K sold.

Howe & Rusling first reported a position in CMD in Q2 2015 and held it in 1 quarter. The position peaked at $16K in Q2 2015. 172 funds tracked by Wall St. Rank hold CMD as of Q3 2015.

  • Howe & Rusling reported no remaining Cantel Medical Corporation position as of Q3 2015 after selling out during the quarter.
  • Howe & Rusling sold 300 Cantel Medical Corporation shares in Q3 2015, an estimated $16K.
  • Howe & Rusling first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 1 quarter.
  • Howe & Rusling's Cantel Medical Corporation position peaked at $16K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2015.

Based on Howe & Rusling's 13F filing for Q3 2015, filed 10 Nov 2015.